UnitedHealth Group Incorporated (NYSE:UNH) Shares Purchased by Waterfront Wealth Inc.

Waterfront Wealth Inc. increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,952 shares of the healthcare conglomerate’s stock after purchasing an additional 51 shares during the period. Waterfront Wealth Inc.’s holdings in UnitedHealth Group were worth $1,028,000 as of its most recent SEC filing.

Other hedge funds also recently made changes to their positions in the company. Richelieu Gestion SA acquired a new stake in shares of UnitedHealth Group in the fourth quarter valued at about $26,000. Robbins Farley purchased a new position in UnitedHealth Group during the 3rd quarter valued at about $25,000. CGC Financial Services LLC increased its holdings in UnitedHealth Group by 1,000.0% during the 4th quarter. CGC Financial Services LLC now owns 55 shares of the healthcare conglomerate’s stock valued at $29,000 after acquiring an additional 50 shares in the last quarter. NewSquare Capital LLC grew its holdings in shares of UnitedHealth Group by 340.0% during the third quarter. NewSquare Capital LLC now owns 66 shares of the healthcare conglomerate’s stock worth $33,000 after buying an additional 51 shares in the last quarter. Finally, LFA Lugano Financial Advisors SA grew its holdings in shares of UnitedHealth Group by 148.1% during the fourth quarter. LFA Lugano Financial Advisors SA now owns 67 shares of the healthcare conglomerate’s stock worth $35,000 after buying an additional 40 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insiders Place Their Bets

In other UnitedHealth Group news, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a filing with the SEC, which is available through this link. In other news, EVP Erin Mcsweeney sold 1,236 shares of the company’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Thomas E. Roos sold 858 shares of the company’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The disclosure for this sale can be found here. Corporate insiders own 0.35% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the topic of several research analyst reports. Oppenheimer reissued an “outperform” rating and issued a $610.00 target price on shares of UnitedHealth Group in a research report on Wednesday, January 17th. Stephens restated an “overweight” rating and issued a $605.00 price target on shares of UnitedHealth Group in a research note on Thursday, February 8th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating for the company in a research note on Friday, April 5th. Finally, Bank of America reiterated a “buy” rating and set a $675.00 target price on shares of UnitedHealth Group in a research note on Thursday, March 7th. Three analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $571.20.

UnitedHealth Group Price Performance

NYSE UNH traded up $10.10 on Wednesday, reaching $478.99. The company’s stock had a trading volume of 8,753,188 shares, compared to its average volume of 4,466,714. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.79 and a current ratio of 0.79. The stock has a market cap of $441.60 billion, a PE ratio of 20.09, a PEG ratio of 1.22 and a beta of 0.54. The firm’s 50 day moving average is $489.51 and its two-hundred day moving average is $515.38.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 6.02% and a return on equity of 26.39%. The company had revenue of $99.80 billion during the quarter, compared to the consensus estimate of $99.23 billion. During the same period in the prior year, the company earned $6.26 EPS. UnitedHealth Group’s revenue was up 8.6% on a year-over-year basis. As a group, sell-side analysts predict that UnitedHealth Group Incorporated will post 27.69 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were issued a dividend of $1.88 per share. The ex-dividend date of this dividend was Friday, March 8th. This represents a $7.52 annualized dividend and a yield of 1.57%. UnitedHealth Group’s payout ratio is presently 31.54%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.